{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:37:40Z","timestamp":1757702260557},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T00:00:00Z","timestamp":1372982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00774-013-0491-4","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T08:12:19Z","timestamp":1372925539000},"page":"298-304","source":"Crossref","is-referenced-by-count":7,"title":["Design of a randomized clinical trial of concurrent treatment with vitamin K2 and risedronate compared to risedronate alone in osteoporotic patients: Japanese Osteoporosis Intervention Trial-03 (JOINT-03)"],"prefix":"10.1007","volume":"32","author":[{"given":"Shiro","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhiko","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiko","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitaka","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hagino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Hosoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitsugu","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Itoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Orimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,5]]},"reference":[{"key":"491_CR1","first-page":"351","volume":"15","author":"H Orimo","year":"2007","unstructured":"Orimo H (2007) The Japanese guidelines for the prevention and treatment of osteoporosis (2006 Edition). Osteoporos Jpn 15:351\u2013355","journal-title":"Osteoporos Jpn"},{"key":"491_CR2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","volume":"13","author":"SP Luckman","year":"1998","unstructured":"Luckman SP, Hughes DE, Coxon FP, Russell RGG, Rogers MJ (1998) Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP binding proteins, including rats. J Bone Miner Res 13:581\u2013589","journal-title":"J Bone Miner Res"},{"key":"491_CR3","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","volume":"333","author":"UA Liberman","year":"1995","unstructured":"Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW, Dequeker J, Favus M, Seeman E, Recker R, Capizzi T, Santora AC, Lombardi A, Shah RV, Hirsch LJ, Karpf DB, For the Alendronate Phase III Osteoporosis Treatment Study Group (1995) Effects of oral alendronate on bone mineral density and the incidence of fracture in postmenopausal osteoporosis. New Engl J Med 333:1437\u20131443","journal-title":"New Engl J Med"},{"key":"491_CR4","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE, For the Fracture Intervention Trial Group (1996) Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fracture. Lancet 348:1535\u20131541","journal-title":"Lancet"},{"key":"491_CR5","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","volume":"282","author":"ST Harris","year":"1999","unstructured":"Harris ST, Watts NB, Genant HK, McKeever EF, Hoseyni MS, Axelrod DW, Miller PD, Vertebral Efficacy with Risedronate Therapy (VERT) study group (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: randomized controlled trial. JAMA 282:1344\u20131352","journal-title":"JAMA"},{"key":"491_CR6","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00198-008-0816-7","volume":"20","author":"T Matsumoto","year":"2009","unstructured":"Matsumoto T, Hagino H, Shiraki M, Fukunaga M, Nakano T, Takaoka K, Morii H, Ohashi Y, Nakamura T (2009) Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study. Osteoporos Int 20:1429\u20131437","journal-title":"Osteoporos Int"},{"key":"491_CR7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00774-007-0790-8","volume":"26","author":"N Tsugawa","year":"2008","unstructured":"Tsugawa N, Shiraki M, Suhara Y, Kamao M, Ozaki R, Tanaka K, Okano T (2008) Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J Bone Miner Metab 26:79\u201385","journal-title":"J Bone Miner Metab"},{"key":"491_CR8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0899-9007(00)00554-2","volume":"17","author":"M Kaneki","year":"2001","unstructured":"Kaneki M, Hodges SJ, Hosoi T, Fujiwara S, Lyons A, Crean SJ, Ishida N, Nakagawa M, Takeuchi M, Sano Y, Mizuno Y, Hoshino S, Miyao M, Inoue S, Horiki K, Shiraki M, Ouchi Y, Orimo H (2001) Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip fracture risk. Nutrition 17:315\u2013321","journal-title":"Nutrition"},{"key":"491_CR9","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1371\/journal.pmed.0050196","volume":"14","author":"AM Cheung","year":"2008","unstructured":"Cheung AM, Tile L, Lee Y, Tomlinson G, Hawker G, Scher J, Hu H, Vieth R, Thompson L, Jamal S, Josse R (2008) Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLoS Med 14:e196","journal-title":"PLoS Med"},{"key":"491_CR10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s007760100002","volume":"6","author":"J Iwamoto","year":"2001","unstructured":"Iwamoto J, Takeda T, Ichimura S (2001) Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: a comparison with the effect of etidronate. J Orthop Sci 6:487\u2013492","journal-title":"J Orthop Sci"},{"key":"491_CR11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1359\/jbmr.2000.15.3.515","volume":"15","author":"M Shiraki","year":"2000","unstructured":"Shiraki M, Shiraki Y, Aoki C, Miura M (2000) Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 15:515\u2013521","journal-title":"J Bone Miner Res"},{"key":"491_CR12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00774-008-0008-8","volume":"27","author":"T Inoue","year":"2009","unstructured":"Inoue T, Fujita T, Kishimoto H, Makino T, Nakamura T, Nakamura T, Sato T, Yamazaki K (2009) Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules. J Bone Miner Metab 27:66\u201375","journal-title":"J Bone Miner Metab"},{"key":"491_CR13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.amjmed.2004.05.019","volume":"117","author":"Y Ishida","year":"2004","unstructured":"Ishida Y, Kawai S (2004) Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study. Am J Med 117:549\u2013555","journal-title":"Am J Med"},{"key":"491_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13450","volume":"13","author":"M Stevenson","year":"2009","unstructured":"Stevenson M, Lloyd-Jones M, Papaioannou D (2009) Vitamin K to prevent fractures in older women: systematic review and economic evaluation. Health Technol Assess 13:1\u2013134","journal-title":"Health Technol Assess"},{"issue":"1","key":"491_CR15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00774-011-0287-3","volume":"30","author":"Y Fang","year":"2012","unstructured":"Fang Y, Hu C, Tao X, Wan Y, Tao F (2012) Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials. J Bone Miner Metab 30(1):60\u201368","journal-title":"J Bone Miner Metab"},{"key":"491_CR16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00774-003-0457-z","volume":"22","author":"M Fukunaga","year":"2004","unstructured":"Fukunaga M, Nakamura T, Shiraki M, Kuroda T, Ohta H, Hosoi T, Orimo H (2004) Absolute height reduction and percent height ratio of the vertebral body in incident fracture in Japanese women. J Bone Miner Metab 22:104\u2013110","journal-title":"J Bone Miner Metab"},{"key":"491_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00774-009-0125-z","volume":"28","author":"K Kumamoto","year":"2010","unstructured":"Kumamoto K, Nakamura T, Suzuki T, Gorai I, Fujinawa O, Ohta H, Shiraki M, Yoh K, Fujiwara S, Endo N, Matsumoto T (2010) Validation of the Japanese osteoporosis quality of life questionnaire. J Bone Miner Metab 28:1\u20137","journal-title":"J Bone Miner Metab"},{"key":"491_CR18","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa032546","volume":"350","author":"JB Meurs","year":"2004","unstructured":"Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350:2033\u20132041","journal-title":"N Engl J Med"},{"key":"491_CR19","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMoa032739","volume":"350","author":"RR McLean","year":"2004","unstructured":"McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350:2042\u20132049","journal-title":"N Engl J Med"},{"key":"491_CR20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00774-010-0191-2","volume":"29","author":"M Shiraki","year":"2011","unstructured":"Shiraki M, Kuroda T, Shiraki Y, Tanaka S, Higuchi T, Saito M (2011) Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment. J Bone Miner Metab 29:62\u201370","journal-title":"J Bone Miner Metab"},{"key":"491_CR21","unstructured":"The Japanese version of National Cancer Institute\u2013Common Toxicity Criteria version 2.0. Available at http:\/\/www.jcog.jp\/doctor\/tool\/C_150_0011.pdf . Accessed 31 Jan 2012"},{"key":"491_CR22","first-page":"469","volume":"22","author":"K Kushida","year":"2004","unstructured":"Kushida K, Fukunaga M, Kishimoto H, Shiraki M, Itabashi A, Inoue T, Kaneda K, Morii H, Nawata H, Yamamoto K, Ohashi Y, Orimo H (2004) A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial. J Bone Miner Metab 22:469\u2013478","journal-title":"J Bone Miner Metab"},{"key":"491_CR23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.nutres.2009.03.012","volume":"29","author":"J Iwamoto","year":"2009","unstructured":"Iwamoto J, Sato Y, Takeda T, Matsumoto H (2009) High-dose vitamin K supplementation reduces fracture incidence in postmenopausal women: a review of the literature. Nutr Res 29:221\u2013228","journal-title":"Nutr Res"},{"key":"491_CR24","unstructured":"Kushima Y, Ishii K, Shimizu K, Sasaki A, Yamamoto K, et al. (2007) Effect of combination therapy with risedronate and vitamin K2 for osteoporosis: Multicentre collaborative study. Preliminary report of a 1-year study. Osteoporos Jpn 15:234\u2013237 (written in Japanese)"},{"key":"491_CR25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s001980070097","volume":"11","author":"R Dowd","year":"2000","unstructured":"Dowd R, Recker RR, Heaney RP (2000) Study subjects and ordinary patients. Osteoporos Int 11:533\u2013536","journal-title":"Osteoporos Int"},{"key":"491_CR26","doi-asserted-by":"crossref","first-page":"11270","DOI":"10.1074\/jbc.M702971200","volume":"283","author":"T Okano","year":"2008","unstructured":"Okano T, Shimomura Y, Yamane M, Suhara Y, Kamao M, Sugiura M, Nakagawa K (2008) Conversion of phylloquinone (Vitamin K1) into menaquinone-4 (Vitamin K2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice. J Biol Chem 283:11270\u201311279","journal-title":"J Biol Chem"},{"key":"491_CR27","doi-asserted-by":"crossref","first-page":"43919","DOI":"10.1074\/jbc.M303136200","volume":"278","author":"MM Tabb","year":"2003","unstructured":"Tabb MM, Sun A, Zhou C, Gr\u00fcn F, Errandi J, Romero K, Pham H, Inoue S, Mallick S, Lin M, Forman BM, Blumberg B (2003) Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 278:43919\u201343927","journal-title":"J Biol Chem"},{"key":"491_CR28","doi-asserted-by":"crossref","first-page":"16927","DOI":"10.1074\/jbc.M600896200","volume":"281","author":"T Ichikawa","year":"2006","unstructured":"Ichikawa T, Horie-Inoue K, Ikeda K, Blumberg B, Inoue S (2006) Steroid and xenobiotic receptor SXR mediates vitamin K2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells. J Biol Chem 281:16927\u201316934","journal-title":"J Biol Chem"},{"key":"491_CR29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/ajcn\/83.2.380","volume":"83","author":"N Tsugawa","year":"2006","unstructured":"Tsugawa N, Shiraki M, Suhara Y, Kamao M, Tanaka K, Okano T (2006) Vitamin K status of healthy Japanese women: age-related vitamin K requirement for gamma-carboxylation of osteocalcin. Am J Clin Nutr 83:380\u2013386","journal-title":"Am J Clin Nutr"},{"key":"491_CR30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00774-008-0034-6","volume":"27","author":"M Shiraki","year":"2009","unstructured":"Shiraki M, Itabashi A (2009) Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study. J Bone Miner Metab 27:333\u2013340","journal-title":"J Bone Miner Metab"},{"key":"491_CR31","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1172\/JCI116387","volume":"91","author":"P Szulc","year":"1993","unstructured":"Szulc P, Chapuy MC, Meunier PJ, Delmas PD (1993) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91:1769\u20131774","journal-title":"J Clin Invest"},{"key":"491_CR32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/jcem.82.3.3847","volume":"82","author":"MJ Seibel","year":"1997","unstructured":"Seibel MJ, Robins SP, Bilezikian JP (1997) Serum undercarboxylated osteocalcin and the risk of hip fracture. J Clin Endocrinol Metab 82:717\u2013718","journal-title":"J Clin Endocrinol Metab"},{"key":"491_CR33","first-page":"719","volume":"82","author":"P Vergnaud","year":"1997","unstructured":"Vergnaud P, Garnero P, Meunier PJ, Br\u00e9art G, Kamihagi K, Delmas PD (1997) Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 82:719\u2013724","journal-title":"J Clin Endocrinol Metab"},{"key":"491_CR34","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1359\/jbmr.2000.15.12.2473","volume":"15","author":"H Luukinen","year":"2000","unstructured":"Luukinen H, K\u00e4k\u00f6nen SM, Pettersson K, Koski K, Laippala P, L\u00f6vgren T, Kivel\u00e4 SL, V\u00e4\u00e4n\u00e4nen HK (2000) Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 15:2473\u20132478","journal-title":"J Bone Miner Res"},{"key":"491_CR35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00198-010-1328-9","volume":"22","author":"S Tanaka","year":"2011","unstructured":"Tanaka S, Narusawa K, Onishi H, Miura M, Hijioka A, Kanazawa Y, Nishida S, Ikeda S, Nakamura T (2011) Lower osteocalcin and osteopontin contents of the femoral head in hip fracture patients than osteoarthritis patients. Osteoporos Int 22:587\u2013597","journal-title":"Osteoporos Int"},{"key":"491_CR36","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00774-010-0167-2","volume":"28","author":"M Shiraki","year":"2010","unstructured":"Shiraki M, Yamazaki Y, Shiraki Y, Hosoi T, Tsugawa N, Okano T (2010) High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment. J Bone Miner Metab 28:578\u2013584","journal-title":"J Bone Miner Metab"},{"key":"491_CR37","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1007\/s00198-009-0888-z","volume":"20","author":"Y Matsumoto","year":"2009","unstructured":"Matsumoto Y, Mikuni-Takagaki Y, Kozai Y, Miyagawa K, Naruse K, Wakao H, Kawamata R, Kashima I, Sakurai T (2009) Prior treatment with vitamin K(2) significantly improves the efficacy of risedronate. Osteoporos Int 20:1863\u20131872","journal-title":"Osteoporos Int"},{"key":"491_CR38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00223-008-9146-1","volume":"83","author":"J Iwamoto","year":"2008","unstructured":"Iwamoto J, Matsumoto H, Takeda T, Sato Y, Liu X, Yeh JK (2008) Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats. Calcif Tissue Int 83:121\u2013128","journal-title":"Calcif Tissue Int"},{"key":"491_CR39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bone.2008.03.023","volume":"44","author":"T Kuroda","year":"2009","unstructured":"Kuroda T, Shiraki M, Tanaka S, Ohta H (2009) Contributions of 25-hydroxyvitamin D, co-morbidities and bone mass to mortality in Japanese postmenopausal women. Bone 44:168\u2013172","journal-title":"Bone"},{"key":"491_CR40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archinte.160.1.77","volume":"160","author":"MC Nevitt","year":"2000","unstructured":"Nevitt MC, Thompson DE, Black DM, Rubin SR, Ensrud K, Yates AJ, Cummings SR (2000) Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group. Arch Intern Med 160:77\u201385","journal-title":"Arch Intern Med"},{"key":"491_CR41","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1185\/03007995.2011.580341","volume":"27","author":"H Orimo","year":"2011","unstructured":"Orimo H, Nakamura T, Fukunaga M, Ohta H, Hosoi T, Uemura Y, Kuroda T, Miyakawa N, Ohashi Y, Shiraki M, A-TOP (Adequate Treatment of Osteoporosis) research group (2011) Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT)-02. Curr Med Res Opin 27:1273\u20131284","journal-title":"Curr Med Res Opin"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-013-0491-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-013-0491-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-013-0491-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:03:50Z","timestamp":1563321830000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-013-0491-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,5]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["491"],"URL":"https:\/\/doi.org\/10.1007\/s00774-013-0491-4","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,5]]}}}